I.v. BU/fludarabine plus melphalan or TBI in unrelated cord blood transplantation for high-risk hematological diseases
- PMID: 25621796
- DOI: 10.1038/bmt.2014.316
I.v. BU/fludarabine plus melphalan or TBI in unrelated cord blood transplantation for high-risk hematological diseases
Similar articles
-
Hepatic injury following reduced intensity unrelated cord blood transplantation for adult patients with hematological diseases.Biol Blood Marrow Transplant. 2006 Dec;12(12):1302-9. doi: 10.1016/j.bbmt.2006.07.013. Biol Blood Marrow Transplant. 2006. PMID: 17162212
-
Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide in Children with Advanced Acute Leukemia with Fludarabine-, Busulfan-, and Melphalan-Based Conditioning.Biol Blood Marrow Transplant. 2016 Mar;22(3):499-504. doi: 10.1016/j.bbmt.2015.11.010. Epub 2015 Nov 21. Biol Blood Marrow Transplant. 2016. PMID: 26612281 Clinical Trial.
-
Reduced intensity conditioning using intravenous busulfan, fludarabine and rabbit ATG for children with nonmalignant disorders and CML.Bone Marrow Transplant. 2006 Feb;37(3):263-9. doi: 10.1038/sj.bmt.1705240. Bone Marrow Transplant. 2006. PMID: 16327813 Clinical Trial.
-
Treatment-related mortality and graft-versus-leukemia activity after allogeneic stem cell transplantation for chronic lymphocytic leukemia using intensity-reduced conditioning.Leukemia. 2003 May;17(5):841-8. doi: 10.1038/sj.leu.2402905. Leukemia. 2003. PMID: 12750695 Review.
-
[Mini-transplantation from cord blood].Nihon Rinsho. 2003 Sep;61(9):1555-60. Nihon Rinsho. 2003. PMID: 14515723 Review. Japanese.
Cited by
-
Examination of a nutritional treatment pathway according to pretreatment health status and stress levels of patients undergoing hematopoietic stem cell transplantation.PLoS One. 2022 Aug 1;17(8):e0271728. doi: 10.1371/journal.pone.0271728. eCollection 2022. PLoS One. 2022. PMID: 35913908 Free PMC article.
-
Hematopoietic stem cell transplantation for acute myeloid leukemia.Int J Hematol. 2018 May;107(5):513-518. doi: 10.1007/s12185-018-2412-8. Epub 2018 Jan 27. Int J Hematol. 2018. PMID: 29374826 Review.
-
Successful Cord Blood Transplantation in a Werner Syndrome Patient with High-risk Myelodysplastic Syndrome.Intern Med. 2019 Jan 1;58(1):109-113. doi: 10.2169/internalmedicine.0317-17. Epub 2018 Aug 24. Intern Med. 2019. PMID: 30146558 Free PMC article.
-
Feasibility of salvage cord blood transplantation using a fludarabine, melphalan, and low-dose anti-thymocyte globulin conditioning regimen.Int J Hematol. 2019 Apr;109(4):463-469. doi: 10.1007/s12185-019-02610-4. Epub 2019 Feb 8. Int J Hematol. 2019. PMID: 30734904
-
Conditioning regimen with a 75% dose of standard busulfan/cyclophosphamide plus fludarabine before cord blood transplantation in older patients with AML and MDS.Int J Hematol. 2019 Sep;110(3):347-354. doi: 10.1007/s12185-019-02688-w. Epub 2019 Jun 13. Int J Hematol. 2019. PMID: 31197737 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical